TradeFlare's AI research teams analysed PLSE on 4 market nights between May 14, 2026 and September 7, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.
| Date | Verdict | Price | Target / stop | 5 days later | 20 days later | Why (that night) |
|---|---|---|---|---|---|---|
| September 7, 2026 | HOLD | $53.24 | — / — | not yet | not yet | The fundamental and risk profiles necessitate a cautious approach, overriding the bullish technicals in the current neutral market. |
| September 3, 2026 | HOLD | $52.68 | — / — | not yet | not yet | The current market conditions and the stock's conflicting team scores necessitate a cautious approach, making short-term observation prudent. |
| September 1, 2026 | HOLD | $50.33 | — / — | not yet | not yet | The technical setup is bullish, but the fundamental and risk profiles are too concerning to initiate a new position. |
| May 14, 2026 | BUY | $23.96 | — / — | not yet | not yet | Continued positive news flow from clinical trial progress. |
Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.